According to these guidelines, the mainstay of hyperglycemia management in the hospital is the administration of insulin, given its high efficacy, flexibility, and lack of interference with most other pharmacotherapies or organ dysfunctions. The gene discussed is INS; the disease is Hyperglycemia.